– 6th Collaborator Program to Reach the Market – LEBANON, N.H., April 15, 2026 /PRNewswire/ -- Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, congratulates GSK plc for recently receiving approvals by the European...
Hence then, the article about adimab collaborator gsk receives additional marketing approval for depemokimab was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab )
Also on site :
- ‘Technofascism’: Critics accuse Palantir of pushing AI war doctrine
- ‘Proud to stand alongside Elon Musk’ – Telegram’s Durov
- Gulf nation warns US it could ditch petrodollar for yuan – WSJ